SENORES PHARMACEUTICALS L - Asset Resilience Ratio

Latest as of September 2025: 21.30%

SENORES PHARMACEUTICALS L (SENORES) has an Asset Resilience Ratio of 21.30% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See financial agility of SENORES PHARMACEUTICALS L to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

Rs2.74 Billion

≈ $29.67 Million USD Cash + Short-term Investments

Total Assets

Rs12.88 Billion

≈ $139.31 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how SENORES PHARMACEUTICALS L's Asset Resilience Ratio has changed over time. See SENORES PHARMACEUTICALS L balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down SENORES PHARMACEUTICALS L's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SENORES market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.74 Billion	21.3%
Total Liquid Assets	Rs2.74 Billion	21.30%

Asset Resilience Insights

Good Liquidity Position: SENORES PHARMACEUTICALS L maintains a healthy 21.30% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

SENORES PHARMACEUTICALS L Industry Peers by Asset Resilience Ratio

Compare SENORES PHARMACEUTICALS L's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AstraZeneca PLC F:ZEGA	Drug Manufacturers - General	0.03%
AstraZeneca PLC NASDAQ:AZN	Drug Manufacturers - General	0.10%
Novartis AG SW:NOVN	Drug Manufacturers - General	0.08%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.48%
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	5.48%
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. SHE:301096	Drug Manufacturers - General	1.58%
Hunan Jingfeng Pharmaceutical SHE:000908	Drug Manufacturers - General	0.38%
Zhejiang Int'L Group Co Ltd SHE:000411	Drug Manufacturers - General	0.00%

Annual Asset Resilience Ratio for SENORES PHARMACEUTICALS L (2022–2024)

The table below shows the annual Asset Resilience Ratio data for SENORES PHARMACEUTICALS L.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-03-31	0.84%	Rs52.08 Million ≈ $563.23K	Rs6.22 Billion ≈ $67.25 Million	-1.18pp
2022-03-31	2.02%	Rs11.95 Million ≈ $129.23K	Rs591.52 Million ≈ $6.40 Million	--

pp = percentage points

About SENORES PHARMACEUTICALS L

NSE:SENORES India Drug Manufacturers - General

Market Cap

$655.14 Million

Rs60.58 Billion INR

Market Cap Rank

#11059 Global

#544 in India

Share Price

Rs1315.40

Change (1 day)

+3.59%

52-Week Range

Rs520.15 - Rs1315.40

All Time High

Rs1315.40